Associate Professor of Internal Medicine (Hematology); Chief Quality Officer, Smilow Cancer Hospital and Yale Cancer Center; Chief, Inpatient Cancer Medicine
Research Interests
Hematologic Diseases
Assistant Professor of Medicine (Hematology)
Research InterestsArthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Director, Center of Molecular and Cellular Oncology; Chief, Division of Basic Science, Yale Cancer Center
Research Interests- Antibody Affinity
- Antibody Specificity
- Arthritis, Rheumatoid
- Autoimmune Diseases
- Autophagy
- B-Lymphocytes
- Burkitt Lymphoma
- Cell Division
- DNA Damage
- Endocytosis
- Energy Metabolism
- Genes, Immunoglobulin
- Hematologic Diseases
- Hodgkin Disease
- Immunity
- Immunologic Deficiency Syndromes
- Leukemia
- Leukemia, Hairy Cell
- Lymphocyte Activation
- Lymphoma
- Lymphoma, Follicular
- Metabolism
- Oxygen Consumption
- Phosphorylation
- Preleukemia
- Receptors, Antigen, B-Cell
- Receptors, Antigen, T-Cell
- Gene Rearrangement
- Signal Transduction
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, T-Cell
- Leukemia-Lymphoma, Adult T-Cell
- Lymphoma, B-Cell
- Lymphoma, T-Cell
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, T-Cell, Cutaneous
- Cell Death
- Lymphoma, Large-Cell, Anaplastic
- Antigen Presentation
- Lymphoma, B-Cell, Marginal Zone
- Molecular Mimicry
- Cell Lineage
- Lymphoma, Mantle-Cell
- Cell Size
- Lipid Metabolism
- Genes, Immunoglobulin Heavy Chain
- Activating Transcription Factors
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Autoimmune Lymphoproliferative Syndrome
- Wnt Signaling Pathway
- Clonal Evolution
- Clonal Selection, Antigen-Mediated
- Immunoreceptor Tyrosine-Based Activation Motif
- Optogenetics
- Cellular Reprogramming
- Plasmablastic Lymphoma
- Oncogene Addiction
Professor of Internal Medicine (Hematology); Acting Director, Stem Cell Transplantation; Chairman, Car-T Cell Joint Steering Committee; Director, Unrelated Donor Transplant Program, Stem Cell Transplantation; Co-Director, Immune Effector Cell Therapy; Co-Director, Adult CAR T-Cell Therapy Program
Research Interests